PHARMACYTE BIOTECH, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHARMACYTE BIOTECH, INC. stock issued during period, shares, new issues for the quarter ending 2019-10-31 was 1.00 shares.
- PHARMACYTE BIOTECH, INC. stock issued during period, shares, new issues for the quarter ending 2017-01-31 was 22.40M shares, a 224.64% increase year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, shares, new issues for the quarter ending 2016-10-31 was 0.00 shares, a 100.00% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, shares, new issues for the quarter ending 2016-07-31 was 66.80M shares, a 574.75% increase year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, shares, new issues for fiscal 2012 was 21.00K shares, a 79.00% decline from fiscal 2011.
- PHARMACYTE BIOTECH, INC. stock issued during period, shares, new issues for fiscal 2011 was 100.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2019-10-31 | 1.00 shares 10-Q · filed 2020-03-13 | |
| 2017-01-31 | 22.40M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-13 | |
| 2016-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-02 | |
| 2016-07-31 | 66.80M shares 10-Q · filed 2016-09-06 | |
| 2016-01-31 | 6.90M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-13 | |
| 2015-10-31 | 4.80M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-02 | |
| 2015-07-31 | 9.90M shares 10-Q · filed 2016-09-06 | |
| 2015-01-31 | 4.96M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | |
| 2014-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | |
| 2014-07-31 | 200.00K shares 10-Q · filed 2014-09-15 | |
| 2014-04-30 | 27.00M shares 10-Q · filed 2014-09-15 | |
| 2012-04-30 | 21.00K shares 10-K · filed 2012-08-14 | |
| 2011-04-30 | 100.00K shares 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |